WuXi XDC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
WuXi XDC - overview
Established
2018
Location
Wuxi, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Wuxi, China, and founded in 2018, WuXi XDC is a medical company. The branches have been set up in Shanghai and Changzhou. As of 2023, the team has more than 1,000 employees. In October 2023, it won the Best Contract Development Manufacturing Provider category at the 2023 World ADC Awards.
In November 2023, the company was listed on the Hong Kong Stock Exchange with stock code 2268 and raised HKD 2. 346 billion in pre-IPO funding. The company is committed to providing single-source discovery, development, and manufacturing services for antibody-drug conjugates (ADCs) and other bio-conjugates. The business includes bio-conjugation discovery, bio-conjugation process development, GMP mAb intermediate and conjugation manufacturing, and so on.
It has served more than 300 clients such as Genentech, Merck, and other companies. The revenue and net income of the company in 2022 were CNY 990. 423 million and CNY 155. 731 million, respectively.
Current Investors
General Atlantic, Novo Holdings, Qatar Investment Authority
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.wuxixdc.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
WuXi XDC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Announced | BioDlink International Company Limited | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.